Immunomonitoring of tumor and exploration of prognostic biomarker using RNAseq data of resected pancreatic cancer

To establish prognostic biomarkers and to identify potential novel therapeutic targets, we performed immunomonitoring of tumor in patients with resectable pancreatic cancer. Gene expression analysis data were obtained by RNAseq.The Data Access Committee of the National Bioscience Database Center (NBDC) approved that this personal genetic data were made published according to NBDC data sharing guidelines (http://humandbs.biosciencedbc.jp/).